ABSTRACT Malignant melanoma has one of the lowest 5‐year survival rates of any cancer and is characterised by its high invasiveness and metastatic potential, with especially poor outcomes in patients who develop brain metastases. Crosstalk between melanoma cells and cells of the tumour microenvironment (TME), including cancer‐associated fibroblasts ...
Mikayla Shelton +8 more
wiley +1 more source
Brief Report: High Levels of CD47 Expression in Thymic Epithelial Tumors
Thomas Sun +9 more
openalex +1 more source
506 CD47 antibody therapy protects circulating red blood cells and platelets from immune destruction [PDF]
Maxim Markovic +3 more
openalex +1 more source
Inhibitory Effects of Circulating Natural Autoantibodies to CD47-derived Peptides on Oral Squamous Cell Carcinoma Cells [PDF]
Xiu Liu +4 more
openalex +1 more source
ABSTRACT Background The authors previously demonstrated that in peripheral blood (PB) of chronic myeloid leukemia (CML), patients’ leukemia stem cells (LSCs) CD26+ are detectable by flow cytometry at diagnosis, during tyrosine kinase inhibitor (TKI) therapy, and during treatment‐free remission.
Anna Sicuranza +30 more
wiley +1 more source
Vaccination with CD47 deficient tumor cells elicits an antitumor immune response in mice [PDF]
Yang Li +5 more
openalex +1 more source
Towards the Application of a Label-Free Approach for Anti-CD47/PD-L1 Bispecific Antibody Discovery [PDF]
A. S. Grevtsev +5 more
openalex +1 more source
Exploring the Prognostic Role of Trop-2, CD47, and CD163 Expression Levels on Survival Outcomes in Patients with Triple-Negative Breast Cancer [PDF]
Ramazan Oğuz Yüceer +5 more
openalex +1 more source
Supplementary Figure S2 from Targeting Fc Receptor-Mediated Effects and the “Don't Eat Me” Signal with an Oncolytic Virus Expressing an Anti-CD47 Antibody to Treat Metastatic Ovarian Cancer [PDF]
Lei Tian +12 more
openalex +1 more source

